Skip to main content
Antibiotice S.A. logo

Antibiotice S.A. - Investor Relations & Filings

Listed IPO Apr 1997
Ticker · ATB ISIN · ROATBIACNOR9 LEI · 315700P5G4O1L6GLMS02 RO Manufacturing
Open in API
Filings indexed 438 across all filing types
Latest filing 2026-07-21 Regulatory Filings
Country RO Romania
Listing RO ATB · 3 venues

Key figures FY2025

Period ended 2025-12-31 · RON
Headline annual figures for Antibiotice S.A., fiscal year 2025, reported in RON, with the source filing for each figure.
Total Revenues RON 645.28M per the Annual Report filed 2026-03-27
Net Income RON 51.77M per the Annual Report filed 2026-03-27
Total Assets RON 1.39B per the Annual Report filed 2026-03-27
Total Equity RON 932.07M per the Annual Report filed 2026-03-27
Cash from Ops RON 72.44M per the Annual Report filed 2026-03-27

As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.

About Antibiotice S.A.

https://www.antibiotice.ro/en/

Antibiotice S.A. is a pharmaceutical company specializing in the development and manufacturing of high-quality generic medicines for human use. The company is a significant producer of anti-infective drugs, with a portfolio that includes injectable penicillins like ampicillin and nafcillin, as well as the active pharmaceutical ingredient (API) Nystatin. It operates eight GMP-certified manufacturing lines and holds US Food and Drug Administration (FDA) approval for key products, underscoring its commitment to global quality standards. The company's mission is to make valuable medicines more accessible to patients, physicians, and pharmacists by providing affordable treatments. Its product range also extends to supplements and skincare products.

Recent filings

Filing Released Lang Actions
Informatii reglementate suplimentare care trebuie publicate in temeiul legislatiei unui stat membru
Regulatory Filings
2026-07-21 Romanian
Disponibilitate raport privind indicatorii cheie de performanta Trim II 2026
Report Publication Announcement Classification · 100% confidence The document is a short announcement (1858 characters) informing stakeholders that a report (the Q2 2026 Key Performance Indicators report) has been published on the company's website. It does not contain the actual financial data or the report itself, but rather provides a link to it and mentions the date for the upcoming financial results presentation. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2026-07-21 Romanian
Informatii reglementate suplimentare care trebuie publicate in temeiul legislatiei unui stat membru
Regulatory Filings Classification · 95% confidence The document is a formal communication from Antibiotice S.A. to the Financial Supervisory Authority (A.S.F.) regarding compliance with reporting obligations under Law no. 24/2017. It details the composition of the Board of Directors, specifically addressing gender representation requirements for board members. As this is a regulatory compliance notification regarding corporate governance structure rather than a financial report, management change announcement, or proxy solicitation, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback for miscellaneous regulatory compliance documents.
2026-07-15 Romanian
Raport curent de informare a investitorilor
Regulatory Filings Classification · 95% confidence The document is a 'Raport curent' (Current Report) issued by Antibiotice S.A. It provides an update on the company's international business strategy, specifically focusing on sales growth in the US market and expansion into the Spanish market. It contains business performance highlights, market outlooks, and strategic updates rather than audited financial statements, dividend declarations, or management changes. As it is a general regulatory announcement regarding company operations and business developments that does not fit into more specific categories like ER or IR, it is classified as a Regulatory Filing (RNS).
2026-06-05 Romanian
Raport Financiar Trimestrial - RFT
Interim / Quarterly Report Classification · 90% confidence The document is titled “Raportul Administratorilor” for January–March 2026 and is a detailed IFRS-compliant quarterly report. It contains substantive financial performance data (revenues, market share, liquidity ratios), operational analysis, and strategic commentary for Q1 2026. It is not merely an announcement; it includes substantive financial statements and management analysis, fitting the definition of an Interim/Quarterly Report rather than an earnings release or simple publication notice. Therefore it should be classified as IR. Q1 2026
2026-05-27 Romanian
Raport curent de informare a investitorilor
Declaration of Voting Results & Voting Rights Announcements Classification · 87% confidence The document is a ‘Raport Curent’ detailing the formal resolutions (‘Hotărârile’) adopted at the Ordinary General Meeting of Shareholders held on 25.05.2026. It includes the vote percentages (“100% for”) and the specific resolution approving the 2026 budget. This matches the profile of an official declaration of voting results at a general meeting, so it falls under Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-25 Romanian

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.